What are the implications of elevated total bilirubin (1.8), direct bilirubin (1.0), alkaline phosphatase (206), and aspartate aminotransferase (AST) (61)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

These lab values suggest liver dysfunction that requires prompt medical evaluation, and you should contact your healthcare provider immediately to discuss these results. The elevated total bilirubin (1.8 mg/dL), direct bilirubin (1.0 mg/dL), alkaline phosphatase (206 U/L), and AST (61 U/L) indicate potential liver disease or biliary obstruction 1. While waiting for medical consultation, avoid alcohol, acetaminophen, and other potentially hepatotoxic medications. Stay well-hydrated and monitor for symptoms like jaundice, dark urine, light-colored stools, abdominal pain, or fatigue.

Some key points to consider:

  • The pattern of elevation (with both direct bilirubin and alkaline phosphatase being high) suggests a possible cholestatic process, which could be due to bile duct obstruction, medication effects, or certain liver diseases 1.
  • Your doctor will likely order additional tests such as ALT, GGT, albumin, and possibly imaging studies like ultrasound or CT scan to determine the underlying cause 1.
  • The interpretation of all abnormal liver chemistries must be taken in the clinical context of a given patient, and the initial evaluation of abnormal liver tests includes a detailed history, inventory of medications, and a physical examination 1.
  • If the initial studies are unrevealing, a reasonable approach may include close clinical follow-up, and if significant symptoms or evidence of chronic or decompensated liver disease are present, a more expeditious and complete initial diagnostic evaluation is typically warranted 1.

Given the most recent and highest quality study available 1, it is essential to seek medical attention promptly to determine the underlying cause of these lab results and to initiate appropriate management to prevent potential complications and improve outcomes.

From the Research

Laboratory Results

  • Total bilirubin: 1.8
  • Direct bilirubin: 1.0
  • Alkaline phosphatase: 206
  • AST: 61

Interpretation of Results

The patient's laboratory results show elevated levels of alkaline phosphatase and AST, which may indicate liver disease or damage 2, 3. The total and direct bilirubin levels are also slightly elevated, which could suggest a problem with the liver's ability to process bilirubin 2.

Possible Causes

The pattern of liver test abnormalities may suggest the underlying cause of the liver disease, such as hepatitis, biliary obstructions, or infiltrative liver disease 2. However, further diagnostic evaluation is needed to determine the etiology of the abnormal liver test results 4, 3.

Next Steps

The initial evaluation should include a review of previous laboratory test results, medical and family histories, substance use, and drugs, including over-the-counter drugs and herbal supplements 3. Additional tests and imaging should be based on patient-specific risk factors and the pattern of abnormal liver test results 3.

Treatment Options

Ursodeoxycholic acid may be a potentially useful drug for chronic liver disease, as it has been shown to improve liver function indices in both cholestatic and inflammatory chronic liver diseases 5, 6. However, the dosage and effectiveness of ursodeoxycholic acid may vary depending on the specific liver disease and patient population 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Laboratory evaluation of the patient with liver disease.

European review for medical and pharmacological sciences, 2004

Research

Care of the Patient With Abnormal Liver Test Results.

Annals of internal medicine, 2021

Research

Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002

Related Questions

Is permethrin safe to use in patients with abnormal liver function tests (LFTs)?
What is the concern with elevated liver function tests (LFTs) in a patient taking cyclobenzaprine (Flexeril) 10mg, duloxetine (Cymbalta) 30mg, gabapentin (Neurontin) 600mg, ibuprofen (Advil) 600mg, olanzapine (Zyprexa) 5mg, and pregabalin (Lyrica) 100mg?
What additional labs are recommended for a patient with hyperbilirubinemia, anemia, and elevated AST?
What is the approach to abnormal Liver Function Tests (LFTs) in primary care?
What initial laboratory tests are recommended for a patient workup?
What is the appropriate workup for a 32-year-old patient with prediabetes and a leukocytosis (White Blood Cell count of 11.4) with a left shift, in the absence of infectious symptoms?
What does the American Academy of Family Physicians (AAFP) recommend for the evaluation of mild asymptomatic thrombocytopenia (low platelet count)?
What immune deficiencies are associated with a low erythrocyte sedimentation rate (ESR) of 2, mild anemia (Hgb 10.2), and a positive Antinuclear Antibody (ANA) test?
What are the implications of discontinuing metformin (Metformin) and starting magenta, presumably a reference to a medication, in an 82-year-old patient with diabetes, undergoing hemodialysis (Hemodialysis) due to impaired renal function, with a history of hypertensive heart disease and chronic diastolic heart failure?
What is the treatment for pediatric right lower lobe pneumonia in a 13-year-old?
What are the implications of discontinuing metformin (Metformin) and initiating linagliptin (Linagliptin) in an 82-year-old patient with diabetes mellitus, undergoing hemodialysis (Hemodialysis), and having hypertensive heart disease with chronic diastolic heart failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.